Neuberger Berman Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-178,880
Closed -$58.2M 1984
2024
Q1
$58.2M Buy
178,880
+35,716
+25% +$8.77M 0.05% 401
2023
Q4
$27.3M Buy
143,164
+67,236
+89% +$12.7M 0.02% 542
2023
Q3
$15.1M Sell
75,928
-9,006
-11% -$2.13M 0.01% 654
2023
Q2
$24.2M Buy
84,934
+30,131
+55% +$8.37M 0.02% 565
2023
Q1
$11.9M Buy
54,803
+42,334
+340% +$8.25M 0.01% 721
2022
Q4
$2.56M Buy
+12,469
New +$3.15M ﹤0.01% 1016

Other funds holding SWAV

Neuberger Berman Group's SWAV Position: Q2 2024 in Review

Neuberger Berman Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 178,880 shares — an estimated $58.2M sold.

Neuberger Berman Group first reported a position in SWAV in Q4 2022 and held it in 6 quarters. The position peaked at $58.2M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Neuberger Berman Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Neuberger Berman Group sold 178,880 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $58.2M.
  • Neuberger Berman Group first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
  • Neuberger Berman Group's Shockwave Medical, Inc. Common Stock position peaked at $58.2M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Neuberger Berman Group's 13F filing for Q2 2024, filed 13 Aug 2024.